{
     "PMID": "12109911",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20020812",
     "LR": "20141120",
     "IS": "0022-2623 (Print) 0022-2623 (Linking)",
     "VI": "45",
     "IP": "15",
     "DP": "2002 Jul 18",
     "TI": "Synthesis and pharmacological testing of 1,2,3,4,10,14b-hexahydro-6-methoxy-2-methyldibenzo[c,f]pyrazino[1,2-a]azepin and its enantiomers in comparison with the two antidepressants mianserin and mirtazapine.",
     "PG": "3280-5",
     "AB": "The synthesis and resolution of 1,2,3,4,10,14b-hexahydro-6-methoxy-2-methyldibenzo[c,f]pyrazino[1,2-a]azepin (6-methoxymianserin, 6) are described. Furthermore, the in vitro and in vivo effects of 6 and its enantiomers are presented. 6 displayed high affinity for the 5-HT2A/2C receptors, only moderate affinity for the adrenoceptors, and no affinity for the NA reuptake site. Surprisingly, 6 also showed moderate to high affinity for the dopamine D2 receptor, an effect that resides in the (R)-(-)-enantiomer.",
     "FAU": [
          "Wikstrom, Hakan V",
          "Mensonides-Harsema, Marguerite M",
          "Cremers, Thomas I F H",
          "Moltzen, Ejner K",
          "Arnt, Jorn"
     ],
     "AU": [
          "Wikstrom HV",
          "Mensonides-Harsema MM",
          "Cremers TI",
          "Moltzen EK",
          "Arnt J"
     ],
     "AD": "Department of Medicinal Chemistry, University Center for Pharmacy, University of Groningen, A. Deusinglaan 1, NL-9713 AV, Groningen, The Netherlands. h.v.wikstrom@farm.rug.nl",
     "LA": [
          "eng"
     ],
     "PT": [
          "Comparative Study",
          "Journal Article"
     ],
     "PL": "United States",
     "TA": "J Med Chem",
     "JT": "Journal of medicinal chemistry",
     "JID": "9716531",
     "RN": [
          "0 (6-methoxymianserin)",
          "0 (Antidepressive Agents)",
          "0 (Receptors, Adrenergic)",
          "0 (Receptors, Dopamine)",
          "0 (Receptors, Histamine)",
          "0 (Receptors, Serotonin)",
          "102-32-9 (3,4-Dihydroxyphenylacetic Acid)",
          "250PJI13LM (Mianserin)",
          "333DO1RDJY (Serotonin)",
          "54-16-0 (Hydroxyindoleacetic Acid)",
          "A051Q2099Q (mirtazapine)",
          "X4W3ENH1CV (Norepinephrine)"
     ],
     "SB": "IM",
     "MH": [
          "3,4-Dihydroxyphenylacetic Acid/metabolism",
          "Animals",
          "Antidepressive Agents/*chemical synthesis/chemistry/*pharmacology",
          "Binding Sites",
          "Hippocampus/drug effects/metabolism",
          "Hydroxyindoleacetic Acid/metabolism",
          "In Vitro Techniques",
          "Male",
          "Mianserin/*analogs & derivatives/*chemical synthesis/chemistry/*pharmacology",
          "Microdialysis",
          "Norepinephrine/metabolism",
          "Radioligand Assay",
          "Rats",
          "Rats, Wistar",
          "Receptors, Adrenergic/metabolism",
          "Receptors, Dopamine/metabolism",
          "Receptors, Histamine/metabolism",
          "Receptors, Serotonin/metabolism",
          "Serotonin/metabolism",
          "Stereoisomerism",
          "Structure-Activity Relationship"
     ],
     "EDAT": "2002/07/12 10:00",
     "MHDA": "2002/08/13 10:01",
     "CRDT": [
          "2002/07/12 10:00"
     ],
     "PHST": [
          "2002/07/12 10:00 [pubmed]",
          "2002/08/13 10:01 [medline]",
          "2002/07/12 10:00 [entrez]"
     ],
     "AID": [
          "jm010566d [pii]"
     ],
     "PST": "ppublish",
     "SO": "J Med Chem. 2002 Jul 18;45(15):3280-5.",
     "term": "hippocampus"
}